Suma Krishnan

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

Joseph Biederman, Suma Krishnan, Yuxin Zhang et al. · Clinical Therapeutics · 2007 · 406 citations

Medicine, Pediatrics, Pharmacology +17

Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study

Joseph Biederman, Samuel W. Boellner, Ann Childress et al. · Biological Psychiatry · 2007 · 358 citations

Medicine, Pharmacology, Pharmacotherapy +16

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

Lenard A. Adler, D. Wayne Goodman, Scott H. Kollins et al. · The Journal of Clinical Psychiatry · 2008 · 220 citations

Medicine, Pharmacology, Pharmacotherapy +15

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

Shireen V. Guide, Mercedes E. González, Brittani Agostini et al. · New England Journal of Medicine · 2022 · 178 citations

Medicine, Dermatology, Pathology +14

In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial

Irina Gurevich, Pooja Agarwal, Peipei Zhang et al. · Nature Medicine · 2022 · 161 citations · Full text

Medicine, Dermatology, Pathology +10